Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for confidential information.
This move became public after a official document from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesman later clarified that the US was demanding access to genetic material for research and profit while refused to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to secure a deal agreeable to both sides so the nation's vital HIV treatment initiative can continue.
Broader Implications
This development follows a similar situation in Kenya, where a court suspended a related deal with the US after concerns were filed about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have to date signed similar agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our country would provide the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our people if a future pandemic arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting systems previously set up via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.
"This system is designed to ensure that when a nation provides its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued discussions with our American counterparts on how subsequent co-operation might be designed in a manner that respects the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations need to persist considering much of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it added.
This impasse emphasises the ongoing tensions between accepting crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.